User: Guest  Login
Title:

The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors.

Document type:
Journal Article
Author(s):
Joachim, Laura; Göttert, Sascha; Sax, Anna; Steiger, Katja; Neuhaus, Klaus; Heinrich, Paul; Fan, Kaiji; Orberg, Erik Thiele; Kleigrewe, Karin; Ruland, Jürgen; Bassermann, Florian; Herr, Wolfgang; Posch, Christian; Heidegger, Simon; Poeck, Hendrik
Abstract:
BACKGROUND: Inter-individual differences in response to immune checkpoint inhibitors (ICI) remain a major challenge in cancer treatment. The composition of the gut microbiome has been associated with differential ICI outcome, but the underlying molecular mechanisms remain unclear, and therapeutic modulation challenging. METHODS: We established an in vivo model to treat C57Bl/6j mice with the type-I interferon (IFN-I)-modulating, bacterial-derived metabolite desaminotyrosine (DAT) to improve ICI...     »
Journal title abbreviation:
EBioMedicine
Year:
2023
Journal volume:
97
Fulltext / DOI:
doi:10.1016/j.ebiom.2023.104834
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/37865045
TUM Institution:
Institut für Allgemeine Pathologie und Pathologische Anatomie (Dr. Mogler komm.); Institut für Klinische Chemie und Pathobiochemie (Prof. Ruland); Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie (Prof. Bassermann)
 BibTeX